DUBLIN, May 1, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sdjlqk/global_generic) has announced the addition of the "Global Generic Drugs Market 2014-2018" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
The analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this market. The market is also witnessing an increase in mergers and acquistions. However, intense competition among vendors could squeeze profit margins, increase pricing pressure, and pose a challenge to the growth of this market.
The report, the Global Generic Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Generic Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space include Actavis plc, Mylan Inc., Novartis International AG (Sandoz), STADA Arzneimittel AG, and Teva Pharmaceutical Industries Ltd.
Other vendors mentioned in the report are 3SBio Inc., Amgen Inc., Apotex Inc., AstraZeneca PLC, Aurobindo Pharma Ltd., Baxter International Inc., Berlin-Chemie AG, Biocon Ltd., Biogen Idec Inc., Boehringer Ingelheim GmbH, Celltrion Inc., Cipla Ltd., Coherus Biosciences Inc., Daiichi Sankyo Co. Ltd., Dr. Reddy's Laboratories Ltd., Emcure Pharmaceuticals Ltd., Gedeon Richter plc, GlaxoSmithKline plc, Hospira Inc., Impax Laboratories Inc., Intas Pharmaceuticals Ltd., Lupin Ltd., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corp., Par Pharmaceutical Inc., Pfizer Inc., Ranbaxy Laboratories Ltd., Roche Holding AG, Sanofi S.A., Wockhardt Ltd., and Zydus Cadila Healthcare Ltd.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Market Segmentation by Category
08. Market Segmentation by Therapeutic Applications
09. Geographical Segmentation
10. Key Leading Countries
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
19. Key Vendor Analysis
20. Other Reports in this Series
Companies Mentioned:
- 3SBio Inc.
- Actavis PLC
- Amgen Inc.
- Apotex Inc.
- AstraZeneca plc
- Aurobindo Pharma Ltd.
- Baxter International Inc.
- Berlin-Chemie AG
- Biocon Ltd.
- Biogen Idec Inc.
- Boehringer Ingelheim GmbH
- Celltrion Inc.
- Cipla Ltd.
- Coherus Biosciences Inc.
- Daiichi Sankyo Co. Ltd.
- Dr. Reddy's Laboratories Ltd.
- Emcure Pharmaceuticals Ltd.
- Gedeon Richter PLC
- GlaxoSmithKline PLC
- Hospira Inc.
- Impax Laboratories Inc.
- Intas Pharmaceuticals Ltd.
- Lupin Ltd.
- Merck & Co. Inc.
- Mitsubishi Tanabe Pharma Corp.
- Mylan Inc.
- Novartis International AG (Sandoz)
- Par Pharmaceutical Inc.
- Pfizer Inc.
- Ranbaxy Laboratories Ltd.
- Roche Holding AG
- STADA Arzneimittel AG
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- Wockhardt Ltd.
- Zydus Cadila Healthcare Ltd.
For more information visit http://www.researchandmarkets.com/research/sdjlqk/global_generic
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
Share this article